Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Hexarelin is a synthetic hexapeptide agonist of the growth hormone secretagogue receptor (GHS-R).1,2 It selectively binds to GHS-R over CD36 (IC50s = 15.9 and 2,080 nM, respectively).1 Hexarelin (300 µg/kg, s.c.) increases plasma growth hormone levels in neonatal rats.2 It also improves left ventricular function and reduces fibrosis in a mouse model of myocardial ischemia induced by transient ligation of the left descending coronary artery (LAD) when administered at a dose of 0.3 mg/kg per day.3
WARNING This product is not for human or veterinary use.
1. Azapeptide analogues of the growth hormone releasing peptide 6 as cluster of differentiation 36 receptor ligands with reduced affinity for the growth hormone secretagogue receptor 1a. J. Med. Chem. 55(14), 502-511 (2012).
2. New active series of growth hormone secretagogues. J. Med. Chem. 46(7), 1191-1203 (2003).
3. Hexarelin targets neuroinflammatory pathways to preserve cardiac morphology and function in a mouse model of myocardial ischemia-